2022 Q4 Form 10-Q Financial Statement

#000121465922014094 Filed on November 22, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4
Revenue $1.504M $1.827M $0.00
YoY Change 6089900.0%
Cost Of Revenue $1.235M $931.0K $0.00
YoY Change 4654900.0%
Gross Profit $269.0K $896.0K $0.00
YoY Change 8959900.0%
Gross Profit Margin 17.89% 49.04%
Selling, General & Admin $1.948M $1.308M $22.59K
YoY Change 8523.28% 6140.46%
% of Gross Profit 724.16% 145.98%
Research & Development $116.0K $71.00K
YoY Change -1.39%
% of Gross Profit 43.12% 7.92%
Depreciation & Amortization $11.00K $10.00K $0.00
YoY Change
% of Gross Profit 4.09% 1.12%
Operating Expenses $2.064M $1.379M $51.45K
YoY Change 3911.66% 6482.34%
Operating Profit -$1.795M -$483.0K -$51.45K
YoY Change 3388.82% 2206.59%
Interest Expense -$2.000K -$3.000K -$13.29K
YoY Change -84.95% -77.17%
% of Operating Profit
Other Income/Expense, Net -$3.000K -$42.08K
YoY Change
Pretax Income -$1.797M -$486.0K -$84.40K
YoY Change 2029.15% 1326.06%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$1.797M -$486.0K -$84.40K
YoY Change 2029.15% 1326.06%
Net Earnings / Revenue -119.48% -26.6%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.04 -$3.005K -$4.521K
COMMON SHARES
Basic Shares Outstanding 172.7M shares 161.7M shares
Diluted Shares Outstanding 43.94M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $95.00K $65.00K $21.78K
YoY Change 336.18% 333.04%
Cash & Equivalents $95.00K $65.00K $21.78K
Short-Term Investments
Other Short-Term Assets $684.0K $756.0K
YoY Change
Inventory $2.595M $2.784M $0.00
Prepaid Expenses $684.0K $1.800M
Receivables $1.022M $1.089M $627.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $4.396M $4.694M $21.78K
YoY Change 20085.51% 18009.57%
LONG-TERM ASSETS
Property, Plant & Equipment $326.0K $248.0K
YoY Change 14071.43%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $270.0K $290.0K $290.0K
YoY Change -6.9%
Total Long-Term Assets $2.257M $2.324M $0.00
YoY Change 26460.0%
TOTAL ASSETS
Total Short-Term Assets $4.396M $4.694M $21.78K
Total Long-Term Assets $2.257M $2.324M $0.00
Total Assets $6.653M $7.018M $21.78K
YoY Change 30449.18% 20142.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.147M $910.0K $4.225K
YoY Change 27047.93% 9147.97%
Accrued Expenses $1.971M $622.0K $4.130K
YoY Change 47623.97% 6379.17%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $45.00K $42.08K
YoY Change -100.0% -54.82%
Long-Term Debt Due $45.00K
YoY Change
Total Short-Term Liabilities $3.731M $2.123M $50.44K
YoY Change 7297.64% 1683.28%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $101.0K $101.5K
YoY Change -100.0%
Other Long-Term Liabilities $1.310M $1.396M
YoY Change
Total Long-Term Liabilities $1.310M $1.497M $101.5K
YoY Change 1190.26%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.731M $2.123M $50.44K
Total Long-Term Liabilities $1.310M $1.497M $101.5K
Total Liabilities $5.041M $3.620M $152.0K
YoY Change 3217.23% 2940.74%
SHAREHOLDERS EQUITY
Retained Earnings -$36.25M -$33.82M -$6.327M
YoY Change 472.99%
Common Stock $173.0K $162.0K $161.7K
YoY Change 6.99%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$23.39M -$21.60M -$130.2K
YoY Change
Total Liabilities & Shareholders Equity $6.653M $7.018M $21.78K
YoY Change 30449.18% 20142.28%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4
OPERATING ACTIVITIES
Net Income -$1.797M -$486.0K -$84.40K
YoY Change 2029.15% 1326.06%
Depreciation, Depletion And Amortization $11.00K $10.00K $0.00
YoY Change
Cash From Operating Activities -$107.0K -$2.544M -$35.23K
YoY Change 203.72% 10980.49%
INVESTING ACTIVITIES
Capital Expenditures $86.00K -$177.0K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$86.00K -$177.0K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 223.0K 2.692M 42.00K
YoY Change 430.95% 12130.8%
NET CHANGE
Cash From Operating Activities -107.0K -2.544M -35.23K
Cash From Investing Activities -86.00K -177.0K 0.000
Cash From Financing Activities 223.0K 2.692M 42.00K
Net Change In Cash 30.00K -29.08K 6.770K
YoY Change 343.13% 2961.05%
FREE CASH FLOW
Cash From Operating Activities -$107.0K -$2.544M -$35.23K
Capital Expenditures $86.00K -$177.0K $0.00
Free Cash Flow -$193.0K -$2.367M -$35.23K
YoY Change 447.83% 10209.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
usd
CY2021Q4 imhc Convertible Notes Payable Non Current
ConvertibleNotesPayableNonCurrent
usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
usd
CY2021Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
usd
CY2021Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
usd
CY2021Q3 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
usd
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
usd
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
shares
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
usd
CY2022Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001349706
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Short Term Lease Cost
ShortTermLeaseCost
usd
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
usd
us-gaap Variable Lease Cost
VariableLeaseCost
usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1905000 usd
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M6D
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
usd
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
usd
CY2021Q4 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
usd
CY2021Q4 us-gaap Debt Current
DebtCurrent
usd
CY2021Q4 us-gaap Debt Conversion Converted Instrument Expiration Or Due Date Day Month And Year
DebtConversionConvertedInstrumentExpirationOrDueDateDayMonthAndYear
2023-12-15
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-52140
dei Entity Registrant Name
EntityRegistrantName
Imperalis Holding Corp.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5648820
dei Entity Address Address Line1
EntityAddressAddressLine1
1421 McCarthy Blvd
dei Entity Address City Or Town
EntityAddressCityOrTown
Milpitas
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95035
dei City Area Code
CityAreaCode
(510)
dei Local Phone Number
LocalPhoneNumber
657-2635
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
172694837 shares
CY2022Q3 us-gaap Cash
Cash
65000 usd
CY2021Q4 us-gaap Cash
Cash
112000 usd
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1089000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
627000 usd
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
756000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1800000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
2784000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
1246000 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
4694000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
3785000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
248000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111000 usd
CY2022Q3 imhc Right Of Use Assets Non Curent
RightOfUseAssetsNonCurent
1786000 usd
CY2021Q4 imhc Right Of Use Assets Non Curent
RightOfUseAssetsNonCurent
244000 usd
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
290000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
290000 usd
CY2022Q3 us-gaap Assets
Assets
7018000 usd
CY2021Q4 us-gaap Assets
Assets
4430000 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
910000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
657000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
546000 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
73000 usd
CY2022Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
45000 usd
CY2022Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
622000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
519000 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2123000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1249000 usd
CY2022Q3 imhc Convertible Notes Payable Non Current
ConvertibleNotesPayableNonCurrent
101000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1396000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
191000 usd
CY2022Q3 us-gaap Liabilities
Liabilities
3620000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1440000 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
25000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
25000 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
25000 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
25000 shares
CY2022Q3 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
1000
CY2021Q4 us-gaap Preferred Stock Redemption Price Per Share
PreferredStockRedemptionPricePerShare
1000
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
25000000 usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
25000000 usd
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161704695 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161704695 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161704695 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161704695 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
162000 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
12052000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9383000 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-33816000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-31393000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-21602000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-22010000 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7018000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4430000 usd
CY2022Q3 us-gaap Revenues
Revenues
1827000 usd
CY2021Q3 us-gaap Revenues
Revenues
1095000 usd
us-gaap Revenues
Revenues
4018000 usd
us-gaap Revenues
Revenues
4308000 usd
CY2022Q3 us-gaap Cost Of Revenue
CostOfRevenue
931000 usd
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
807000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2269000 usd
us-gaap Cost Of Revenue
CostOfRevenue
2644000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
896000 usd
CY2021Q3 us-gaap Gross Profit
GrossProfit
288000 usd
us-gaap Gross Profit
GrossProfit
1749000 usd
us-gaap Gross Profit
GrossProfit
1664000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
71000 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
72000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
581000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
368000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
766000 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
536000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2386000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1456000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
542000 usd
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
176000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1202000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
600000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1379000 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
784000 usd
us-gaap Operating Expenses
OperatingExpenses
4169000 usd
us-gaap Operating Expenses
OperatingExpenses
2424000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-483000 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-496000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2420000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-760000 usd
CY2022Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-3000 usd
CY2022Q3 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-3000 usd
us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-3000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-486000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-496000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2423000 usd
us-gaap Net Income Loss
NetIncomeLoss
-760000 usd
CY2022Q3 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
139000 usd
us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
139000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-625000 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-496000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2562000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-760000 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43941493 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14808122 shares
CY2022Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
-22010000 usd
CY2022Q1 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
1010000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-933000 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-21933000 usd
CY2022Q2 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
1250000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1004000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-21687000 usd
CY2022Q3 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
409000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
162000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-486000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-21602000 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-24726000 usd
CY2021Q1 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
673000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-298000 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-24351000 usd
CY2021Q2 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
1161000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
34000 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-23156000 usd
CY2021Q3 us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
1076000 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-496000 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-22576000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2423000 usd
us-gaap Net Income Loss
NetIncomeLoss
-760000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
40000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
18000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
363000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
51000 usd
imhc Increase In Net Parent Investment For Corporate Overhead
IncreaseInNetParentInvestmentForCorporateOverhead
240000 usd
imhc Increase In Net Parent Investment For Corporate Overhead
IncreaseInNetParentInvestmentForCorporateOverhead
247000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
462000 usd
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-110000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-1044000 usd
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1775000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1538000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
176000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
253000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-457000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-227000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-45000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
148000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
240000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2562000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2547000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
177000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-177000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2591000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
2663000 usd
us-gaap Proceeds From Repayments Of Debt
ProceedsFromRepaymentsOfDebt
101000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2692000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2663000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-47000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
116000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
112000 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
258000 usd
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
65000 usd
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
374000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1905000 usd
us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
162000 usd
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2005-04-05
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
100000 usd
CY2022Q3 us-gaap Capital
Capital
2600000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1827000 usd
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1095000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4018000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4308000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_zs4mX6ZHJMQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i><span id="xdx_868_zTA06TP2D1k2">Accounting Estimates</span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements, in conformity with GAAP, requires management to make estimates, judgments and assumptions. The Company’s management believes that the estimates, judgments, and assumptions used are reasonable based upon information available at the time they are made. These estimates, judgments and assumptions can affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates. Key estimates include allowances for inventory obsolescence, accruals of certain liabilities including product warranties, useful lives of assets, and valuation allowance related to deferred tax assets.</p>
CY2022Q3 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
54000 usd
CY2021Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
54000 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_845_eus-gaap--ConcentrationRiskCreditRisk_zC8k6Qnba0M5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 2pt 0pt 0; text-align: justify"><b><i><span id="xdx_869_z8JcrTboDPpc">Concentration of Credit R<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>isk</i></b></span></span></i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and trade receivables.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Trade receivables of the Company and its subsidiaries are mainly derived from sales to customers located primarily in the U.S. The Company performs ongoing credit evaluations of its customers and to date has not experienced any material losses. At September 30, 2022, receivables from three customers made up 47% of the current receivables but the majority of the balances were outstanding for less than 90 days. Greater than 90 day receivables balance was less than 1%. At December 31, 2021 four customers made up 49% of the outstanding receivables with only one customer being the same customer as referred to with respect to the September 30, 2022 concentration.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An allowance for doubtful accounts is determined with respect to those amounts that the Company and its subsidiaries have determined to be doubtful of collection. As of September 30, 2022 and December 31, 2021, there were no allowances for doubtful accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <p id="xdx_891_eus-gaap--ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock_zOI54IXS8wh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span id="xdx_8BF_z8TsNGPuQZQb">The following table provides the percentage of total revenue attributable to a single customer from which 10% or more of total revenue is derived:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">For the Nine Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; white-space: nowrap"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">September 30, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">September 30, 2022</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total Revenue</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Percentage of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total Revenue</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Percentage of</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">by Major</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total Company</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">by Major</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total Company</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt; white-space: nowrap"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Customers</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Customer</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">Revenue</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--Revenues_c20220701__20220930__srt--MajorCustomersAxis__custom--CustomerAMember_zQd9roB15cq" style="width: 15%; text-align: right" title="Revenues">300,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__srt--MajorCustomersAxis__custom--CustomerAMember_ze3vRbJ5I8qf" title="Concentration risk, percentage">27</span></td><td style="white-space: nowrap; width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--Revenues_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerAMember_zlPZxaVtFrq6" style="width: 15%; text-align: right" title="Revenues">563,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--CustomerAMember_zjx0MmTFBei5" title="Concentration risk, percentage">14</span></td><td style="white-space: nowrap; width: 1%; text-align: left">%</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">For the Three Months Ended</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center">For the Nine Months Ended</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="6" style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: center">September 30, 2021</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total Revenue</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Percentage of</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total Revenue</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Percentage of</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">by Major</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total Company</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">by Major</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Total Company</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1pt"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Customer</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenue</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Customer</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Revenue</td><td style="white-space: nowrap; padding-bottom: 1pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Customer A</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--Revenues_c20210701__20210930__srt--MajorCustomersAxis__custom--CustomerAMember_zFxcD05otIb" style="width: 15%; text-align: right" title="Revenues">279,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210701__20210930__srt--MajorCustomersAxis__custom--CustomerAMember_z2hehrP8zCyk" title="Concentration risk, percentage">25</span></td><td style="white-space: nowrap; width: 1%; text-align: left">%</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_eus-gaap--Revenues_c20210101__20210930__srt--MajorCustomersAxis__custom--CustomerAMember_zgo79D234iMl" style="width: 15%; text-align: right" title="Revenues">933,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 15%; text-align: right"><span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20210101__20210930__srt--MajorCustomersAxis__custom--CustomerAMember_zR1C3msmwsSk" title="Concentration risk, percentage">22</span></td><td style="white-space: nowrap; width: 1%; text-align: left">%</td></tr> </table> <p id="xdx_8AC_zg02UZAdyWr8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/>
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161704695 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161704695 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
21478923 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
0 shares
CY2022Q3 us-gaap Revenues
Revenues
1827000 usd
CY2021Q3 us-gaap Revenues
Revenues
1095000 usd
us-gaap Revenues
Revenues
4018000 usd
us-gaap Revenues
Revenues
4308000 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
900000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1412000 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
652000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1301000 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
248000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
111000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
10000 usd
CY2021Q3 us-gaap Depreciation
Depreciation
6000 usd
us-gaap Depreciation
Depreciation
40000 usd
us-gaap Depreciation
Depreciation
18000 usd
CY2022Q3 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
959000 usd
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
594000 usd
CY2022Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1824000 usd
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
652000 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
2784000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
1246000 usd
CY2022Q3 us-gaap Customer Advances Current
CustomerAdvancesCurrent
270000 usd
CY2021Q4 us-gaap Customer Advances Current
CustomerAdvancesCurrent
259000 usd
CY2022Q3 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
128000 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
46000 usd
CY2022Q3 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
224000 usd
CY2021Q4 us-gaap Accrued Payroll Taxes Current And Noncurrent
AccruedPayrollTaxesCurrentAndNoncurrent
214000 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
622000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
519000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1786000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
546000 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1396000 usd
CY2022Q3 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
162000 usd
us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
486000 usd
us-gaap Proceeds From Operating Activities
ProceedsFromOperatingActivities
350000 usd
CY2022Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.08 pure
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
167000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Two
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
682000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Three
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
693000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Four
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
609000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due In Rolling Year Five
LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
51000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2202000 usd
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
260000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1942000 usd
CY2022Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
2000 usd
CY2021Q3 us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 usd
us-gaap Revenue From Related Parties
RevenueFromRelatedParties
0 usd
CY2022Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0.001
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
161704695 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
161704695 shares
CY2022Q3 us-gaap Business Combination Control Obtained Description
BusinessCombinationControlObtainedDescription
On September 5, 2022, the Company entered into an amendment to the Agreement, pursuant to which the Company agreed to (i) use commercially reasonable efforts to effectuate a distribution by the Parent of 140,000,000 shares of common stock beneficially owned by the Parent (the “Distribution”) and, (ii) to issue to Parent warrants to purchase an equivalent number of shares of common stock to be issued in the Distribution (the “Warrants”). The Distribution has not yet occurred.
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
17000 usd
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
146000 usd
CY2022Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
45000 usd
CY2022Q3 us-gaap Debt Current
DebtCurrent
101000 usd
us-gaap Conversion Of Stock Shares Converted1
ConversionOfStockSharesConverted1
10990142 shares

Files In Submission

Name View Source Status
0001214659-22-014094-index-headers.html Edgar Link pending
0001214659-22-014094-index.html Edgar Link pending
0001214659-22-014094.txt Edgar Link pending
0001214659-22-014094-xbrl.zip Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
i111122510q.htm Edgar Link pending
imhc-20220930.xsd Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
imhc-20220930_cal.xml Edgar Link unprocessable
i111122510q_htm.xml Edgar Link completed
imhc-20220930_def.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
imhc-20220930_lab.xml Edgar Link unprocessable
imhc-20220930_pre.xml Edgar Link unprocessable